4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-458244
Co-Chief Executive Officer sold 100,000 shares at an average $29.84 ($2,983,678)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/ownership.xml…